Skip to main content

Animations

Illustrated close up of DNA.

Research Tools Catalog

To save researchers time and resources, The Michael J. Fox Foundation has made a number of tools available to the scientific community at low cost, with rapid delivery.

Helpful Resources

  • Illustrated adjacent hexagons.

    Sponsored Tools Program

    Learn more about how MJFF can help share your tools.

  • Illustrated Parkinson's Disease Research Tools Consortium logo.

    Tools Consortium

    MJFF is working with industry to develop priority tools.

  • Illustrated brain on a presentation display.

    Preclinical Models

    Learn more about the various in vivo models used in Parkinson's disease research.

Find a Research Tool

Filter by Tool Type or Gene/Protein Type to Organize Results

* = MJFF does not control pricing or terms of availability for this tool. 

Filters
Sort by
Order
Filters
Sort by
Order
Sort by
Order
Results (294)
Sort by:
Total Rab 8 Antibody (Hu)
Antibody
Rabbit monoclonal antibody directed against the human total Rab 8 protein. Suitable for immunoblot, immunostaining, flow cytometry, and immunoprecipitation experiments. Epitope was mapped to amino acids 189-199.
  • Rab
Total Rab 8 Antibody (Hu/Ms/Rt)
Antibody
Rabbit monoclonal antibody directed against the human and rodent total Rab 8 protein. Suitable for immunoblot and immunoprecipitation experiments. This antibody epitope was mapped to C-terminus amino acids 190-196.
  • Rab
Ubiquitin pS65 Phosphospecific Antibody (IHC)
Antibody
Rat anti-pS65 Ubiquitin antibody that has undergone Fc species switching to develop rat reagents from the original rabbit antibody (41H1/41K3). The new chimeric antibody is approved for immunohistochemistry and can be detected using Fc-specific secondary antibodies to rat IgG.
  • Ubiquitin
Ubiquitin pS65 Phosphospecific Antibody (IHC)
Antibody
Rabbit monoclonal phosphospecific antibody directed against Serine65 of ubiquitin. Suitable for immunohistochemistry applications. Detailed characterization data is published in Watzlawik et al, Autophagy 2024
  • Ubiquitin
Ubiquitin pS65 Phosphospecific Antibody (Ms ELISA)
Antibody
Rabbit monoclonal phosphospecific antibody directed against Serine65 of mouse ubiquitin. Suitable for ELISA applications. Detailed characterization data is published in Watzlawik et al, Autophagy 2024
  • Ubiquitin
Ubiquitin pS65 Phosphospecific Antibody (WB/ICC/ELISA)
Antibody
Rat anti-pS65 Ubiquitin antibody that has undergone Fc species switching to develop rat reagents from the original rabbit antibody (30H3/30K1). The new chimeric antibody is approved for immunoblotting, immunocytochemistry, and immunoassay, and can be detected using Fc-specific secondary antibodies to rat IgG.
  • Ubiquitin
Ubiquitin pS65 Phosphospecific Antibody (WB/ICC/ELISA)
Antibody
Rabbit monoclonal phosphospecific antibody directed against Serine65 of ubiquitin. Suitable for immunoblot, immunocytochemistry, and ELISA applications. Detailed characterization data is published in Watzlawik et al, Autophagy 2024.   
  • Ubiquitin
Ubiquitinated-K266 VDAC1 Antibody
Antibody
Monoclonal antibody directed against ubiquitinated-K266 VDAC1. Please note: The antibody will not be made available as QC/QA of the antibody showed a lack of adequate sensitivity. Email tools@michaeljfox.org with questions or for more information.   
  • VDAC1
VPS13C Antibody
Antibody
Rabbit monoclonal antibody directed against human/mouse VPS13C for immunoblotting and immunostaining applications.  Estimated Availability: Early 2025
  • VPS13C
VPS13C Edited iPSC Lines
Human iPS Cell
KOLF2.1J human iPSC line with CRISPR-engineered mutations in VPS13C, including heterozygous and homozygous G1389R, heterozygous and homozygous R117*, and homozygous knockout mutations. These lines were generated within the iPSC Neurodegeneration Initiative for Parkinson’s Disease (iNDI-PD) which is supported by Aligning Science Across Parkinson's (ASAP). Estimated Availability: Q1 2026.
  • VPS13C
Have questions or need additional information?

Email tools@michaeljfox.org with questions and to suggest new tools for us to develop. Or visit our FAQ page. 

"We have shown, thanks in part to MJFF, that researchers now have in their pantry the right ‘ingredients’, to... help to drive forward PD drug development.”
Heather Melrose, PhD Mayo Clinic
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.